Patent No. EP4070788 (titled "Pharmaceutical Formulations") was filed by Gilead Sciences on Jun 29, 2016. The application was issued on Mar 22, 2023.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
| Company | Opposition Date | Representative |
|---|---|---|
| ZENTIVA | Dec 11, 2023 | REDDIE & GROSE |
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
Jun 25, 2025
Jun 24, 2025
Jun 23, 2025
Jun 20, 2025
Jun 20, 2025
Jun 20, 2025
Jun 17, 2025
Jun 17, 2025
Jun 17, 2025
Apr 25, 2025
Apr 25, 2025
Apr 22, 2025
Apr 22, 2025
Apr 22, 2025
Apr 10, 2025
Apr 10, 2025
Apr 4, 2025
Apr 4, 2025
Apr 4, 2025
Feb 21, 2025
Feb 21, 2025
Feb 21, 2025
Feb 21, 2025
Feb 21, 2025
Feb 21, 2025
Feb 21, 2025
Feb 21, 2025
Feb 21, 2025
Feb 21, 2025
Feb 21, 2025
Feb 21, 2025
Feb 21, 2025
Feb 3, 2025
Jan 24, 2025
Jan 23, 2025
Jan 23, 2025
Jan 23, 2025
Jan 22, 2025
Jan 22, 2025
Jan 22, 2025
Jan 21, 2025
Jan 16, 2025
Jan 16, 2025
Jan 16, 2025
Dec 9, 2024
Dec 6, 2024
Dec 4, 2024
Dec 4, 2024
Dec 3, 2024
Dec 3, 2024
Dec 3, 2024
Dec 3, 2024
Dec 3, 2024
Dec 3, 2024
Dec 3, 2024
Dec 3, 2024
Dec 3, 2024
Dec 3, 2024
Dec 3, 2024
Dec 3, 2024
Dec 3, 2024
Dec 3, 2024
Dec 3, 2024
Dec 3, 2024
Dec 3, 2024
Dec 3, 2024
Dec 3, 2024
Dec 3, 2024
Dec 3, 2024
Dec 3, 2024
Dec 3, 2024
Dec 3, 2024
Dec 3, 2024
Dec 3, 2024
Dec 3, 2024
Jul 24, 2024
Jul 24, 2024
Jul 4, 2024
Jul 4, 2024
Jul 4, 2024
Jul 4, 2024
Jul 4, 2024
May 17, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 13, 2024
Jan 12, 2024
Jan 12, 2024
Dec 15, 2023
Dec 11, 2023
Dec 11, 2023
Dec 11, 2023
Dec 11, 2023
Dec 11, 2023
Dec 11, 2023
Dec 11, 2023
Dec 11, 2023
Apr 4, 2023
Feb 23, 2023
Feb 8, 2023
Feb 8, 2023
Feb 8, 2023
Feb 8, 2023
Feb 8, 2023
Jan 27, 2023
Jan 27, 2023
Jan 27, 2023
Jan 27, 2023
Jan 27, 2023
Jan 27, 2023
Jan 13, 2023
Jan 13, 2023
Jan 13, 2023
Jan 13, 2023
Jan 13, 2023
Jan 13, 2023
Jan 13, 2023
Dec 15, 2022
Dec 15, 2022
Dec 15, 2022
Dec 15, 2022
Dec 15, 2022
Dec 15, 2022
Nov 29, 2022
Nov 9, 2022
Nov 9, 2022
Nov 9, 2022
Nov 9, 2022
Nov 9, 2022
Nov 9, 2022
Oct 17, 2022
Sep 14, 2022
Aug 31, 2022
Aug 26, 2022
Aug 26, 2022
Aug 26, 2022
Aug 10, 2022
Jul 25, 2022
Jul 15, 2022
Jul 15, 2022
Jul 15, 2022
Jul 15, 2022
Jul 15, 2022
Jul 15, 2022
May 31, 2022
May 31, 2022
May 31, 2022
May 31, 2022
May 31, 2022
May 31, 2022
May 31, 2022
May 31, 2022
May 31, 2022
Jan 23, 2017
Jan 23, 2017
Jan 23, 2017
Jan 23, 2017